Literature DB >> 8313940

Expression of Escherichia coli beta-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer.

B L Davidson1, S E Doran, D S Shewach, J M Latta, J W Hartman, B J Roessler.   

Abstract

Adenoviral-mediated gene transfer to the caudate nucleus of Macaca mulatta was accomplished using stereotactic injection of two distinct recombinant Ad5 vectors containing the gene for Escherichia coli beta-galactosidase and the cDNA for rat hypoxanthine-guanine phosphoribosylphosphotransferase (HPRT), respectively. Multiple analyses (including immunohistochemistry, histochemistry, transmission electron microscopy, RNA in situ hybridization, nucleotide pool analysis, and enzyme assay) confirmed efficient expression of beta-galactosidase and rat HPRT. Transgene expression was evident in both neurons and glia. Clinically, no evidence of meningitis or cerebritis was observed and no focal neurological deficits were detected in the animal. These preliminary studies indicate that recombinant adenovirus is capable of mediating high level transgene expression to the brains of higher order mammals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8313940     DOI: 10.1006/exnr.1994.1028

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  15 in total

1.  rab5 GTPase regulates adenovirus endocytosis.

Authors:  T Rauma; J Tuukkanen; J M Bergelson; G Denning; T Hautala
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Novel methods for adenovirus-mediated gene transfer to blood vessels in vivo.

Authors:  H Ooboshi; C D Ríos; D D Heistad
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

Review 3.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

4.  Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector.

Authors:  U Blömer; L Naldini; T Kafri; D Trono; I M Verma; F H Gage
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

5.  Adenoviruses encoding HPRT correct biochemical abnormalities of HPRT-deficient cells and allow their survival in negative selection medium.

Authors:  T D Southgate; D Bain; L D Fairbanks; A E Morelli; A T Larregina; H A Simmonds; M G Castro; P R Löwenstein
Journal:  Metab Brain Dis       Date:  1999-12       Impact factor: 3.584

6.  Comparison of intracerebral inoculation and osmotic blood-brain barrier disruption for delivery of adenovirus, herpesvirus, and iron oxide particles to normal rat brain.

Authors:  L L Muldoon; G Nilaver; R A Kroll; M A Pagel; X O Breakefield; E A Chiocca; B L Davidson; R Weissleder; E A Neuwelt
Journal:  Am J Pathol       Date:  1995-12       Impact factor: 4.307

7.  Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors.

Authors:  Andrew I Brooks; Colleen S Stein; Stephanie M Hughes; Jason Heth; Paul M McCray; Sybille L Sauter; Julie C Johnston; Deborah A Cory-Slechta; Howard J Federoff; Beverly L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

8.  Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer.

Authors:  T Li; B L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

9.  Group D adenoviruses infect primary central nervous system cells more efficiently than those from group C.

Authors:  M Chillon; A Bosch; J Zabner; L Law; D Armentano; M J Welsh; B L Davidson
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  Beta cyclodextrins enhance adenoviral-mediated gene delivery to the intestine.

Authors:  M A Croyle; B J Roessler; C P Hsu; R Sun; G L Amidon
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.